Cholangiocyte proliferation and liver fibrosis

Cholangiocyte proliferation is triggered during extrahepatic bile duct obstruction induced by bile duct ligation, which is a common in vivo model used for the study of cholangiocyte proliferation and liver fibrosis. The proliferative response of cholangiocytes during cholestasis is regulated by the complex interaction of several factors, including gastrointestinal hormones, neuroendocrine hormones and autocrine or paracrine signalling mechanisms. Activation of biliary proliferation (ductular reaction) is thought to have a key role in the initiation and progression of liver fibrosis. The first part of this review provides an overview of the primary functions of cholangiocytes in terms of secretin-stimulated bicarbonate secretion – a functional index of cholangiocyte growth. In the second section, we explore the important regulators, both inhibitory and stimulatory, that regulate the cholangiocyte proliferative response during cholestasis. We discuss the role of proliferating cholangiocytes in the induction of fibrosis either directly via epithelial mesenchymal transition or indirectly via the activation of other liver cell types. The possibility of targeting cholangiocyte proliferation as potential therapy for reducing and/or preventing liver fibrosis, and future avenues for research into how cholangiocytes participate in the process of liver fibrogenesis are described.

[1]  A. Benedetti,et al.  Control of Cholangiocyte Adaptive Responses by Visceral Hormones and Neuropeptides , 2009, Clinical reviews in allergy & immunology.

[2]  P. Gartside,et al.  Bile duct changes in alcoholic liver disease , 2008 .

[3]  N. LaRusso,et al.  Cholangiocyte primary cilia are chemosensory organelles that detect biliary nucleotides via P2Y12 purinergic receptors. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[4]  J. Medina-Pestana,et al.  Serum levels of YKL‐40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection , 2008, Journal of viral hepatitis.

[5]  Hong Wang,et al.  Interaction of CD44 and hyaluronic acid enhances biliary epithelial proliferation in cholestatic livers. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[6]  D. Schuppan,et al.  Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. , 2008, Gastroenterology.

[7]  A. Franchitto,et al.  Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway. , 2008, American journal of physiology. Cell physiology.

[8]  A. Torrice,et al.  Insulin-like growth factor-1 isoforms in rat hepatocytes and cholangiocytes and their involvement in protection against cholestatic injury , 2008, Laboratory Investigation.

[9]  R. Mancinelli,et al.  Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanisms. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[10]  M. Ebrahimkhani,et al.  Wound healing and local neuroendocrine regulation in the injured liver , 2008, Expert Reviews in Molecular Medicine.

[11]  H. Friess,et al.  Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. , 2008, Journal of hepatology.

[12]  F. Marra,et al.  Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario. , 2008, Molecular aspects of medicine.

[13]  M. Pekalski,et al.  Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease , 2008, Laboratory Investigation.

[14]  Ji Won Kim,et al.  Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. , 2008, Human pathology.

[15]  G. Rasi,et al.  Nerve growth factor involvement in liver cirrhosis and hepatocellular carcinoma. , 2007, World journal of gastroenterology.

[16]  S. Glaser,et al.  Knockout of α-calcitonin gene-related peptide reduces cholangiocyte proliferation in bile duct ligated mice , 2007, Laboratory Investigation.

[17]  S. Glaser,et al.  Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis. , 2007, Gastroenterology.

[18]  H. Tilg,et al.  Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. , 2007, Gastroenterology.

[19]  N. Voelkel,et al.  VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice. , 2007, American journal of physiology. Cell physiology.

[20]  Merlin C. Thomas,et al.  The Role of Tubular Epithelial-Mesenchymal Transition in Progressive Kidney Disease , 2007, Cells Tissues Organs.

[21]  A. Franchitto,et al.  H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway , 2007, Laboratory Investigation.

[22]  S. Glaser,et al.  Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[23]  David C. Jones,et al.  Biliary epithelial‐mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis , 2007, Hepatology.

[24]  J. Sicklick,et al.  Hedgehog-mediated mesenchymal–epithelial interactions modulate hepatic response to bile duct ligation , 2007, Laboratory Investigation.

[25]  N. LaRusso,et al.  Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate. , 2007, Gastroenterology.

[26]  S. Glaser,et al.  Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. , 2007, Gastroenterology.

[27]  M. Harbeck,et al.  Cell physiology of cAMP sensor Epac , 2006, The Journal of physiology.

[28]  H. Yoshiji,et al.  Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development. , 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

[29]  T. Springer,et al.  Integrin structures and conformational signaling. , 2006, Current opinion in cell biology.

[30]  J. Sicklick,et al.  Evidence for epithelial-mesenchymal transitions in adult liver cells. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[31]  L. Bryan-Lluka,et al.  A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. , 2006, The American journal of pathology.

[32]  A. Franchitto,et al.  Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[33]  S. Glaser,et al.  Heterogeneity of the intrahepatic biliary epithelium. , 2006, World journal of gastroenterology.

[34]  G. Svegliati-Baroni,et al.  Estrogens maintain bile duct mass and reduce apoptosis after biliodigestive anastomosis in bile duct ligated rats. , 2006, Journal of hepatology.

[35]  T. Roskams,et al.  Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases , 2006, Hepatology.

[36]  Yan-chun Zhou,et al.  Modulation of expression and function of Toll-like receptor 3 in A549 and H292 cells by histamine. , 2006, Molecular immunology.

[37]  G. Stoica,et al.  Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. , 2006, Gastroenterology.

[38]  S. Glaser,et al.  Adrenergic receptor agonists prevent bile duct injury induced by adrenergic denervation by increased cAMP levels and activation of Akt. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[39]  Tao Li,et al.  Effects of 5-hydroxytamine and its antagonists on hepatic stellate cells. , 2006, Hepatobiliary & pancreatic diseases international : HBPD INT.

[40]  C. Ganellin,et al.  Histamine and its receptors , 2006, British journal of pharmacology.

[41]  B. Rehermann,et al.  The liver as an immunological organ , 2004 .

[42]  A. Franchitto,et al.  The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis. , 2005, Journal of hepatology.

[43]  A. Vercelli,et al.  Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis. , 2005, World journal of gastroenterology.

[44]  W. Grizzle,et al.  Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome. , 2005, Gastroenterology.

[45]  S. Glaser,et al.  Secretin activation of the apical Na+‐dependent bile acid transporter is associated with cholehepatic shunting in rats , 2005, Hepatology.

[46]  M. Richardson,et al.  Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis , 2005, Hepatology.

[47]  T. Roskams,et al.  Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. , 2005, Gastroenterology.

[48]  A. Franchitto,et al.  Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. , 2004, Journal of hepatology.

[49]  N. LaRusso,et al.  The cholangiopathies: disorders of biliary epithelia. , 2004, Gastroenterology.

[50]  S. Glaser,et al.  cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway. , 2004, Journal of hepatology.

[51]  S. Glaser,et al.  Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. , 2004, Gastroenterology.

[52]  E. Brambilla,et al.  Expression of vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1 [Flt-1] and VEGF-R2 [KDR/Flk-1]) in tumorlets and in neuroendocrine cell hyperplasia of the lung. , 2004, Human pathology.

[53]  G. Tiegs,et al.  Innervation of immune cells: evidence for neuroimmunomodulation in the liver. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[54]  N. LaRusso,et al.  The Pathophysiology of Biliary Epithelia , 2004 .

[55]  E. Gaudio,et al.  Tamoxifen in treatment of primary biliary cirrhosis , 2004, Hepatology.

[56]  G. Tiegs,et al.  Neurokinin-1 Receptor Antagonists Protect Mice from CD95- and Tumor Necrosis Factor-α-Mediated Apoptotic Liver Damage , 2004, Journal of Pharmacology and Experimental Therapeutics.

[57]  N. Sinelli,et al.  Hepatic fibrogenesis requires sympathetic neurotransmitters , 2004, Gut.

[58]  Simi Ali,et al.  Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition. , 2004, Journal of the American Society of Nephrology : JASN.

[59]  T. Patel,et al.  Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct-ligated rats. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[60]  S. Glaser,et al.  Gastrin reverses established cholangiocyte proliferation and enhanced secretin‐stimulated ductal secretion of BDL rats by activation of apoptosis through increased expression of Ca2+‐dependent PKC isoforms , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[61]  A. Vollmar,et al.  Neurokinin-1 Receptor Antagonists CP-96,345 and L-733,060 Protect Mice from Cytokine-Mediated Liver Injury , 2003, Journal of Pharmacology and Experimental Therapeutics.

[62]  R. Hultcrantz,et al.  The Myofibroblastic Conversion of Peribiliary Fibrogenic Cells Distinct from Hepatic Stellate Cells Is Stimulated by Platelet-Derived Growth Factor During Liver Fibrogenesis , 2003, Laboratory Investigation.

[63]  D. Drucker Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. , 2003, Molecular endocrinology.

[64]  L. Boros,et al.  Cultured pancreatic ductal cells undergo cell cycle re-distribution and beta-cell-like differentiation in response to glucagon-like peptide-1. , 2002, Journal of molecular endocrinology.

[65]  A. Franchitto,et al.  Intracellular pathways mediating estrogen‐induced cholangiocyte proliferation in the rat , 2002, Hepatology.

[66]  S. Morini,et al.  Effect of ovariectomy on the proliferative capacity of intrahepatic rat cholangiocytes. , 2002, Gastroenterology.

[67]  S. Sumitran-Holgersson,et al.  High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6 , 2002, Gut.

[68]  S. Glaser,et al.  Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha , 2002, Hepatology.

[69]  M. Tammi,et al.  Hyaluronan and Homeostasis: A Balancing Act* , 2002, The Journal of Biological Chemistry.

[70]  M. Válková Hepatic fibrogenesis. , 2002, Bratislavske lekarske listy.

[71]  D. Wendum,et al.  Hepatic Stellate Cell Proliferation is an Early Platelet-Derived Growth Factor-Mediated Cellular Event in Rat Cholestatic Liver Injury , 2001, Laboratory Investigation.

[72]  S. Glaser,et al.  Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes , 2001, Hepatology.

[73]  H. Mitomi,et al.  Significant correlations of E-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas. , 2001, American journal of clinical pathology.

[74]  S. Glaser,et al.  Regulation of cholangiocyte bicarbonate secretion. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[75]  S. Glaser,et al.  Regression of cholangiocyte proliferation after cessation of ANIT feeding is coupled with increased apoptosis. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[76]  M. Beckmann,et al.  Hormone Replacement Therapy after Treatment of Breast Cancer: Effects on Postmenopausal Symptoms, Bone Mineral Density and Recurrence Rates , 2001, Oncology.

[77]  D. Schuppan,et al.  Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. , 2001, The American journal of pathology.

[78]  A. Franchitto,et al.  Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. , 2000, Gastroenterology.

[79]  F. Pierau,et al.  Inhibitory neurogenic modulation of histamine-induced cutaneous plasma extravasation in the pigeon , 2000, Regulatory Peptides.

[80]  N F LaRusso,et al.  Alternative splicing of the rat sodium/bile acid transporter changes its cellular localization and transport properties. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[81]  S. Glaser,et al.  Gastrin inhibits cholangiocyte growth in bile duct–ligated rats by interaction with cholecystokinin‐B/gastrin receptors via D ‐myo‐inositol 1,4,5‐triphosphate–, Ca2+‐, and protein kinase C α–dependent mechanisms , 2000 .

[82]  D. Schuppan,et al.  An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis. , 2000, Gastroenterology.

[83]  J. Bajorath Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions , 2000, Proteins.

[84]  H. Herbst,et al.  Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats. , 1999, Journal of hepatology.

[85]  S. Glaser,et al.  Cholinergic system modulates growth, apoptosis, and secretion of cholangiocytes from bile duct-ligated rats. , 1999, Gastroenterology.

[86]  Jones Ea,et al.  The pathogenesis and treatment of pruritus and fatigue in patients with PBC. , 1999 .

[87]  S. Glaser,et al.  Acute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from BDL rat liver. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[88]  I. Shimizu,et al.  Suppressive effects of estradiol on dimethylnitrosamine‐induced fibrosis of the liver in rats , 1999, Hepatology.

[89]  J. Olynyk,et al.  Oval cell numbers in human chronic liver diseases are directly related to disease severity. , 1999, The American journal of pathology.

[90]  S. Glaser,et al.  Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver , 1999, Hepatology.

[91]  S. Glaser,et al.  Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. , 1999, Gastroenterology.

[92]  N. Bergasa,et al.  The pathogenesis and treatment of pruritus and fatigue in patients with PBC. , 1999, European journal of gastroenterology & hepatology.

[93]  V. Desmet,et al.  Ductular reaction and its diagnostic significance. , 1998, Seminars in diagnostic pathology.

[94]  N. LaRusso,et al.  Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[95]  L. Miller,et al.  Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors. , 1998, Gastroenterology.

[96]  N. LaRusso,et al.  The pathobiology of biliary epithelia , 2002, Hepatology.

[97]  P. Dawson,et al.  Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter. , 1997, The Journal of clinical investigation.

[98]  S. Glaser,et al.  Functional expression of the apical Na+-dependent bile acid transporter in large but not small rat cholangiocytes. , 1997, Gastroenterology.

[99]  S. Glaser,et al.  Gastrin inhibits secretin-induced ductal secretion by interaction with specific receptors on rat cholangiocytes. , 1997, American journal of physiology. Gastrointestinal and liver physiology.

[100]  S. Glaser,et al.  Role and mechanisms of action of acetylcholine in the regulation of rat cholangiocyte secretory functions. , 1997, The Journal of clinical investigation.

[101]  S. Glaser,et al.  Bile acids stimulate proliferative and secretory events in large but not small cholangiocytes. , 1997, The American journal of physiology.

[102]  S. Glaser,et al.  gamma-Interferon inhibits secretin-induced choleresis and cholangiocyte proliferation in a murine model of cirrhosis. , 1997, Journal of hepatology.

[103]  J. Boyer,et al.  Role of kinases and phosphatases in the regulation of fluid secretion and Cl-/HCO3- exchange in cholangiocytes. , 1997, The American journal of physiology.

[104]  M. Swain,et al.  Improvement in cholestasis‐associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment , 1997, Hepatology.

[105]  S. Glaser,et al.  Regrowth of the rat biliary tree after 70% partial hepatectomy is coupled to increased secretin-induced ductal secretion. , 1996, Gastroenterology.

[106]  A. Gentilini,et al.  Inhibition by pentoxifylline of extracellular signal‐regulated kinase activation by platelet‐derived growth factor in hepatic stellate cells , 1996, British journal of pharmacology.

[107]  L. Pannarale,et al.  Hepatic microcirculation and peribiliary plexus in experimental biliary cirrhosis: a morphological study. , 1996, Gastroenterology.

[108]  Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. , 1996, Endocrine reviews.

[109]  I. Stamenkovic,et al.  Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan , 1996, The Journal of cell biology.

[110]  N. LaRusso,et al.  Somatostatin inhibits secretin-induced ductal hypercholeresis and exocytosis by cholangiocytes. , 1995, The American journal of physiology.

[111]  P. van Eyken,et al.  Ductular reaction in the liver. , 1995, Pathology, research and practice.

[112]  J. Medina,et al.  Immunohistochemical detection of chloride/bicarbonate anion exchangers in human liver , 1994, Hepatology.

[113]  N. LaRusso,et al.  Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. , 1994, The American journal of physiology.

[114]  T. Gettys,et al.  Secretin activates Cl- channels in bile duct epithelial cells through a cAMP-dependent mechanism. , 1994, The American journal of physiology.

[115]  D. Lagunoff,et al.  Somatostatin analogue (octreotide) inhibits bile duct epithelial cell proliferation and fibrosis after extrahepatic biliary obstruction. , 1993, The American journal of pathology.

[116]  J. Boyer,et al.  Effect of secretion on intracellular pH regulation in isolated rat bile duct epithelial cells. , 1993, The Journal of clinical investigation.

[117]  P. Gartside,et al.  Bile duct changes in alcoholic liver disease. The Veterans Administration Cooperative Study Group. , 1993, Liver.

[118]  W. Meyers,et al.  Secretin receptors in a new preparation of plasma membranes from intrahepatic biliary epithelium. , 1993, The Journal of surgical research.

[119]  M. Iwai,et al.  Alteration in sympathetic nerve activity during liver regeneration in rats after partial hepatectomy. , 1992, Journal of the autonomic nervous system.

[120]  T. Maudelonde,et al.  Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1. , 1992, The Journal of clinical endocrinology and metabolism.

[121]  H. Stein,et al.  Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. , 1991, The American journal of pathology.

[122]  J. Boyer,et al.  Mechanisms and regulation of bile secretion , 1991, Hepatology.

[123]  R Williams,et al.  Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis , 1991, Hepatology.

[124]  V. Desmet,et al.  Neuroendocrine features of reactive bile ductules in cholestatic liver disease. , 1990, The American journal of pathology.

[125]  H. Stein,et al.  Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis. , 1990, Gastroenterology.

[126]  H. Stein,et al.  Cellular localization of laminin gene transcripts in normal and fibrotic human liver. , 1989, The American journal of pathology.

[127]  D. DiPette,et al.  Dose-dependent systemic and regional hemodynamic effects of calcitonin gene-related peptide. , 1989, The American journal of the medical sciences.

[128]  L. Sarkozi,et al.  Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. , 1988, The Journal of clinical investigation.

[129]  J. Tippins CGRP: a novel neuropeptide from the calcitonin gene is the most potent vasodilator known. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[130]  Umezu Kohei,et al.  Change of hepatic histamine content during hepatic fibrosis. , 1985 .

[131]  H. Morris,et al.  Calcitonin gene-related peptide is a potent vasodilator , 1985, Nature.

[132]  S. Yuasa,et al.  Change of hepatic histamine content during hepatic fibrosis. , 1985, Biochemical pharmacology.

[133]  D. Chalbos,et al.  Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). , 1982, The Journal of clinical endocrinology and metabolism.